Klaria Pharma Holding AB KLAR

Morningstar Rating
SEK 0.56 −0.04 (7.35%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

KLAR is trading at a LOCK|Zdkwl premium.
Price
SEK 0.56
Fair Value
LOCK|Tkzb&B
Uncertainty
LOCK|gTS#$
1-Star Price
LOCK|&R>%NZK
5-Star Price
LOCK|?sd!@BM
Economic Moat
LOCK|<^!
Capital Allocation
—

Trading Information

Previous Close Price
SEK 0.60
Day Range
SEK 0.55–0.60
52-Week Range
SEK 0.45–1.33
Bid/Ask
SEK 0.56 / SEK 0.57
Shares Outstanding
245.98M
Market Cap
SEK 136.52M
Volume/Avg
1M / 712,640

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
868.54
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Klaria Pharma Holding AB is a Swedish pharmaceutical company that develops rapid-acting products. By combining patented technology of a film that attaches to the oral mucosa and pharmaceuticals, the company has developed a drug distribution concept with many benefits and potential uses. Its patented drug delivery platform consists of an alginate-based polymer film that enables the absorption of a product's active substance through the oral mucosa.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
4

Valuation

Metric
KLAR
Price/Earnings (Normalized)
—
Price/Book Value
—
Price/Sales
868.54
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
KLAR
Quick Ratio
0.20
Current Ratio
0.20
Interest Coverage
−4.45
Quick Ratio
KLAR

Profitability

Metric
KLAR
Return on Assets (Normalized)
−97.91%
Return on Equity (Normalized)
—
Return on Invested Capital (Normalized)
—
Return on Assets
KLAR

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|jDHs?&$LOCK|<#N<k$68B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|>#x@%szLOCK|LL^w$$46B
Haleon PLC ADR
HLN
LOCK|P$?cvB#LOCK|q&$39B
Zoetis Inc Class A
ZTS
LOCK|g&>&N!>LOCK|StK$29B
Viatris Inc
VTRS
LOCK|Cl^!#>LOCK|d<$20B
Elanco Animal Health Inc
ELAN
LOCK|CD?LOCK|pNx$11B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|#hQ@SK^LOCK|gF$10B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|k>S?!HLOCK|sy>$7B
Prestige Consumer Healthcare Inc
PBH
LOCK|rJ>KV$!LOCK|%BPpy$2B
Perrigo Co PLC
PRGO
LOCK|wJcN%Y^LOCK|l!$2B

Sponsor Center